BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 27924350)

  • 1. [Use of intracutaneous or subcutaneous botulinum toxin for postherpetic neuralgia].
    Halb L; Amann BJ; Bornemann-Cimenti H
    Nervenarzt; 2017 Apr; 88(4):408-414. PubMed ID: 27924350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum Toxin for Neuropathic Pain: A Review of the Literature.
    Oh HM; Chung ME
    Toxins (Basel); 2015 Aug; 7(8):3127-54. PubMed ID: 26287242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Intradermal Botulinum Toxin Injections on Herpes Zoster Related Neuralgia.
    Peng F; Xia TB
    Infect Drug Resist; 2023; 16():2159-2165. PubMed ID: 37077249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Botulinum toxin type A in the treatment of neuropathic pain in a case of postherpetic neuralgia].
    Ruiz Huete C; Bermejo P
    Neurologia; 2008 May; 23(4):259-62. PubMed ID: 18516748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum Toxin for the Treatment of Neuropathic Pain.
    Park J; Park HJ
    Toxins (Basel); 2017 Aug; 9(9):. PubMed ID: 28837075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneous Injection of Botulinum Toxin in Patients with Post Herpetic Neuralgia. A Preliminary Study.
    Jain P; Jain M; Jain S
    J Assoc Physicians India; 2018 Jul; 66(7):48-49. PubMed ID: 31325262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventional Treatments for Postherpetic Neuralgia: A Systematic Review.
    Lin CS; Lin YC; Lao HC; Chen CC
    Pain Physician; 2019 May; 22(3):209-228. PubMed ID: 31151330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous and perineural botulinum toxin type a for neuropathic pain: a descriptive review.
    Fabregat G; De Andrés J; Villanueva-Pérez VL; Asensio-Samper JM
    Clin J Pain; 2013 Nov; 29(11):1006-12. PubMed ID: 23370086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous botulinum toxin-A injection for treating postherpetic neuralgia.
    Hu Y; Zou L; Qi X; Lu Y; Zhou X; Mao Z; Chen X; Liu K; Yang Y; Wu Z; Hu Y; Ma S
    Dermatol Ther; 2020 Jan; 33(1):e13181. PubMed ID: 31769900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous injection of botulinum toxin a is beneficial in postherpetic neuralgia.
    Xiao L; Mackey S; Hui H; Xong D; Zhang Q; Zhang D
    Pain Med; 2010 Dec; 11(12):1827-33. PubMed ID: 21134121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Postherpetic neuralgia].
    Goßrau G
    Nervenarzt; 2015 Feb; 86(2):219-28; quiz 229-30. PubMed ID: 25659844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum Toxin Treatment of Neuropathic Pain.
    Mittal SO; Safarpour D; Jabbari B
    Semin Neurol; 2016 Feb; 36(1):73-83. PubMed ID: 26866499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of Botulinum Toxin A and Pulsed Radiofrequency on Postherpetic Neuralgia: A Randomized Clinical Trial.
    Chen L; Zhang Y; Chen Y; Wang T; Sun K; Tang H; Shen W; Ji F
    Contrast Media Mol Imaging; 2022; 2022():1579937. PubMed ID: 35685657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Botulinum Toxin in Orofacial Clinical Practice.
    Serrera-Figallo MA; Ruiz-de-León-Hernández G; Torres-Lagares D; Castro-Araya A; Torres-Ferrerosa O; Hernández-Pacheco E; Gutierrez-Perez JL
    Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32053883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Naumann M; So Y; Argoff CE; Childers MK; Dykstra DD; Gronseth GS; Jabbari B; Kaufmann HC; Schurch B; Silberstein SD; Simpson DM;
    Neurology; 2008 May; 70(19):1707-14. PubMed ID: 18458231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Botulinum toxin A injections in neuropathic pain : A post-hoc subgroup analysis of patients with peripheral nerve injury].
    Eitner L; Vollert J; Maier C; Attal N
    Schmerz; 2017 Oct; 31(5):524-526. PubMed ID: 28660416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Postherpetic neuralgia].
    Goßrau G
    Hautarzt; 2014 May; 65(5):461-70; quiz 471-2. PubMed ID: 24820804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pain sensation during intradermal injections of three different botulinum toxin preparations in different doses and dilutions.
    Kranz G; Sycha T; Voller B; Gleiss A; Schnider P; Auff E
    Dermatol Surg; 2006 Jul; 32(7):886-90. PubMed ID: 16875469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin for neuropathic pain and spasticity: an overview.
    Brown EA; Schütz SG; Simpson DM
    Pain Manag; 2014 Mar; 4(2):129-51. PubMed ID: 24641437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of Botulinum Toxin in the Treatment of Neuropathic Pain: A Literature Review.
    Dekhne A; Goklani HD; Doshi N; Baskara Salian R; Gandhi SK; Patel P
    Cureus; 2023 Oct; 15(10):e46848. PubMed ID: 37954779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.